Published in Am J Gastroenterol on September 04, 2008
Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2014) 1.40
Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer (2010) 1.10
Chemoprevention and Barrett's esophagus: decisions, decisions. Am J Gastroenterol (2008) 0.84
Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus. Cancer Prev Res (Phila) (2011) 0.77
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
Explaining risks: turning numerical data into meaningful pictures. BMJ (2002) 8.28
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.65
The framing effect of relative and absolute risk. J Gen Intern Med (1993) 4.87
Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology (2000) 4.74
The lifetime risk of stroke: estimates from the Framingham Study. Stroke (2006) 4.68
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology (2003) 3.90
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart (2001) 3.88
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med (2002) 3.84
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology (2002) 2.88
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med (2006) 2.73
Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med (2005) 2.34
The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst (2002) 2.13
The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology (2005) 1.91
iMPACT3: Internet-based development and administration of utility elicitation protocols. Med Decis Making (2002) 1.90
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst (2007) 1.65
Medical decision analysis of chemoprevention against esophageal adenocarcinoma. Gastroenterology (2003) 1.08
Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection? Postgrad Med (1999) 0.95
The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals. Cancer (2004) 0.86
Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus. Dis Esophagus (2007) 0.80
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42
Comprehensive volumetric optical microscopy in vivo. Nat Med (2006) 5.19
Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med (2012) 4.72
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol (2008) 2.74
Paraesophageal hernias: operation or observation? Ann Surg (2002) 2.71
Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review. BMJ (2014) 2.62
Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med (2013) 2.32
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc (2006) 2.31
Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst (2012) 2.30
Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (2010) 2.28
Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc (2007) 2.26
Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer (2003) 2.22
Directional distribution of neoplasia in Barrett's esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc (2013) 2.08
Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak (2013) 1.99
Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc (2010) 1.79
Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79
The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65
Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. AJR Am J Roentgenol (2011) 1.56
Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med (2012) 1.52
Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making (2004) 1.51
An approach to measuring the quality of breast cancer decisions. Patient Educ Couns (2006) 1.50
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci (2014) 1.44
Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42
Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat (2011) 1.39
Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol (2008) 1.37
A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail (2006) 1.36
Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol (2009) 1.34
Calibration of disease simulation model using an engineering approach. Value Health (2009) 1.27
A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res (2008) 1.27
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26
Cost-effectiveness of whole-body CT screening. Radiology (2005) 1.25
XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis (2007) 1.25
Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health (2008) 1.24
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Temporally and spectrally resolved fluorescence spectroscopy for the detection of high grade dysplasia in Barrett's esophagus. Lasers Surg Med (2003) 1.21
Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol (2006) 1.20
Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med (2005) 1.15
Comprehensive imaging of gastroesophageal biopsy samples by spectrally encoded confocal microscopy. Gastrointest Endosc (2009) 1.15
Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc (2002) 1.14
Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology (2002) 1.14
Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making (2006) 1.14
Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer (2014) 1.13
Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology (2008) 1.13
Diagnostic imaging costs: are they driving up the costs of hospital care? Radiology (2005) 1.11
Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology (2002) 1.11
Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow. Transplantation (2005) 1.11
Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology (2010) 1.09
Multiple-fiber probe design for fluorescence spectroscopy in tissue. Appl Opt (2002) 1.09
Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol (2007) 1.09
Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol (2007) 1.09
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci (2003) 1.07
Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol (2008) 1.07
Optoacoustic tomography using time-resolved interferometric detection of surface displacement. J Biomed Opt (2003) 1.05
Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal (2012) 1.05
Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology (2008) 1.04
Elective endovascular versus open surgical repair of abdominal aortic aneurysms: systematic review of short-term results. Radiology (2002) 1.03
Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol (2004) 1.03
Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol (2005) 1.02
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis (2008) 1.01
The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol (2007) 0.99
Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: a pilot study conducted on biopsy specimens. Gastrointest Endosc (2011) 0.98
Abdominal and pelvic computed tomography (CT) interpretation: discrepancy rates among experienced radiologists. Eur Radiol (2010) 0.98
Falling prey to the sunk cost bias: a potential harm of patient radiation dose histories. Radiology (2012) 0.97
An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology (2004) 0.96
Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol (2002) 0.95
Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist (2011) 0.95
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer (2011) 0.94
Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology (2003) 0.94
Cost-effectiveness of PET in the diagnosis of Alzheimer disease. Radiology (2003) 0.93
Adoption and spread of new imaging technology: a case study. Health Aff (Millwood) (2009) 0.93
Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Ann Pharmacother (2006) 0.93
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc (2002) 0.92
Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma. J Clin Oncol (2010) 0.92
Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology (2004) 0.92
Appropriateness and utilization of cardiac CT: implications for development of future criteria. J Nucl Cardiol (2010) 0.91
The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91
What we talk about when we talk about low-grade dysplasia. Gut (2014) 0.91
Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer (2012) 0.90
Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc (2008) 0.89
CT screening: a trade-off of risks, benefits, and costs. J Clin Invest (2003) 0.89
Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci (2009) 0.87
Biomedical Imaging Research Opportunities Workshop: report and recommendations. Radiology (2003) 0.87
Endoscopic confocal microscopy. Curr Opin Gastroenterol (2005) 0.87
Doing the right thing: systems support for decision quality in cancer care. Ann Behav Med (2006) 0.87
Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87
The use of optical coherence tomography in screening and surveillance of Barrett's esophagus. Clin Gastroenterol Hepatol (2005) 0.87